公开(公告)号：US11804289B2

公开(公告)日：2023-10-31

申请号：US17123598

申请日：2020-12-16

Applicant: DexCom, Inc.

Inventor： Stephen D. Patek

IPC: G16H20/17 ,  G16H40/67 ,  A61B5/00 ,  G16H10/60 ,  A61B5/145 ,  G16H50/30 ,  G16H70/40 ,  G16H20/10 ,  G16H20/60 ,  G06F40/40 ,  G16H15/00 ,  G16H50/70 ,  G16H50/20 ,  G06F16/26 ,  A61M5/172

CPC classification number: G16H20/17 ,  A61B5/14532 ,  A61B5/7275 ,  G06F16/26 ,  G06F40/40 ,  G16H10/60 ,  G16H15/00 ,  G16H20/10 ,  G16H20/60 ,  G16H40/67 ,  G16H50/20 ,  G16H50/30 ,  G16H50/70 ,  G16H70/40 ,  A61M5/1723 ,  A61M2230/201

Abstract: Systems and methods are provided for identifying therapeutic zones where there is glycemic dysfunction of a specific type that can be addressed by making strategic changes to behavior and/or therapy parameters. Systems and methods described herein evaluate large historical data sets to: identify a therapeutic zone or zones with glycemic dysfunction that are most readily addressable; quantify the glycemic impact of a plurality of different therapeutic adjustments in terms of either adjustments to historical doses or the parameters of a prospective dosing strategy to determine the highest possible improvement; and/or identify patient dosing strategies to provide therapy recommendations adapted for the patient's preferred behavioral dosing strategy.

公开(公告)号：US20230338654A1

公开(公告)日：2023-10-26

申请号：US18139427

申请日：2023-04-26

Applicant: Dexcom, Inc.

Inventor： Stephen D. Patek ,  Matthew S. Gerber ,  Enrique Campos-Nanez ,  Thibault Gautier ,  Leah Ziegler

IPC: A61M5/172 ,  A61M5/168

CPC classification number: A61M5/1723 ,  A61M5/16877 ,  A61M2202/0486 ,  A61M2205/50

Abstract: A continuous glucose monitor (CGM)-driven basal insulin titration system and method for patients with Type 2 Diabetes can be adapted to the needs and concerns of subjects just starting on basal insulin therapy. The method uses as inputs historical CGM data, basal insulin dose information, reports of hypoglycemia, and past recommendations and generates an adjusted insulin dose along with a report advising whether to continue the titration process, or to stop. The method can generate a new recommendation on a regular basis (e.g., each day) until it determines an adequate, consistent dose size.

公开(公告)号：US11797250B2

公开(公告)日：2023-10-24

申请号：US17814215

申请日：2022-07-21

Applicant: Dexcom, Inc.

Inventor： Hari Hampapuram ,  Eric Cohen ,  Brian Christopher Smith ,  Jose Hector Hernandez-Rosas ,  Francis William Pascual ,  Michael Robert Mensinger ,  Shawn Larvenz

IPC: G06F3/14 ,  G16H40/63 ,  H04W76/14 ,  H04W76/11 ,  G16Z99/00 ,  A61B5/00 ,  A61B5/145 ,  G09G5/00

CPC classification number: G06F3/1423 ,  A61B5/0004 ,  A61B5/14532 ,  A61B5/742 ,  A61B5/7445 ,  G06F3/1454 ,  G09G5/003 ,  G16H40/63 ,  G16Z99/00 ,  H04W76/11 ,  H04W76/14 ,  G09G2358/00 ,  G09G2370/16 ,  G09G2380/08

Abstract: A continuous glucose monitor for wirelessly transmitting data relating to glucose value to a plurality of displays is disclosed, as well as systems and methods for limiting the number of display devices that can connect to a continuous glucose transmitter. In addition, security, including hashing techniques and a changing application key, can be used to provide secure communications between the continuous glucose transmitter and the displays. Also provided is a continuous glucose monitor and techniques for authenticating multiple displays, providing secure data transmissions to multiple displays, and coordinating the interaction of commands and data updates between multiple displays.

公开(公告)号：US20230329633A1

公开(公告)日：2023-10-19

申请号：US18336782

申请日：2023-06-16

Applicant: Dexcom, Inc.

Inventor： Stephen D. Patek

IPC: A61B5/00 ,  G16H20/17 ,  A61M5/172 ,  G16H50/30 ,  H04N21/435 ,  H04N21/44 ,  G06N3/04 ,  G06N3/0455 ,  H04N19/70

CPC classification number: A61B5/4839 ,  G16H20/17 ,  A61B5/7275 ,  A61M5/1723 ,  G16H50/30 ,  H04N21/435 ,  H04N21/44 ,  G06N3/04 ,  G06N3/0455 ,  H04N19/70 ,  A61M2230/201

Abstract: Systems and methods are provided for managing hyperglycemia and hypoglycemia by reconciling incoming data to provide safe and reliable control to range using automatic bolus determination wherein the rate of insulin delivery is dependent on the level of hyperglycemic risk or hypoglycemic risk. Additionally, some implementations are directed to converting insulin delivery into a rate based on glycemic risk.

公开(公告)号：US20230328893A1

公开(公告)日：2023-10-12

申请号：US18205365

申请日：2023-06-02

Applicant: DexCom, Inc.

Inventor： Jason M. Halac ,  John Charles Barry ,  Becky L. Clark ,  Chris W. Dring ,  John Michael Gray ,  Kris Elliot Higley ,  Jeff Jackson ,  David A. Keller ,  Ted Tang Lee ,  Jason Mitchell ,  Kenneth Pirondini ,  David Rego ,  Ryan Everett Schoonmaker ,  Peter C. Simpson ,  Craig Thomas Gadd ,  Kyle Thomas Stewart ,  John Stanley Hayes

IPC: H05K3/32 ,  A61B5/1486 ,  A61B5/145 ,  G01N27/327 ,  A61B5/1495 ,  A61B5/00 ,  A61M15/00 ,  G16H20/17 ,  G16H40/63 ,  A61M5/142 ,  A61M5/172 ,  A61M5/20 ,  A61M11/00 ,  A61M35/00 ,  A61B5/1459 ,  A61B5/1473

CPC classification number: H05K3/321 ,  A61M5/003 ,  A61B5/14532 ,  G01N27/3273 ,  A61B5/1495 ,  A61B5/6849 ,  A61M15/0068 ,  A61M15/008 ,  A61M15/0083 ,  G16H20/17 ,  G16H40/63 ,  A61B5/14546 ,  A61M5/14244 ,  A61M5/14276 ,  A61M5/1723 ,  A61M5/20 ,  A61M11/00 ,  A61M15/0065 ,  A61M35/00 ,  G01N27/3274 ,  A61B5/1459 ,  A61B5/1473 ,  A61B5/6801 ,  A61B2562/085 ,  A61B2562/12 ,  A61B2562/08 ,  A61B5/0031 ,  A61B5/14865

Abstract: Pre-connected analyte sensors are provided. A pre-connected analyte sensor includes a sensor carrier attached to an analyte sensor. The sensor carrier includes a substrate configured for mechanical coupling of the sensor to testing, calibration, or wearable equipment. The sensor carrier also includes conductive contacts for electrically coupling sensor electrodes to the testing, calibration, or wearable equipment.

公开(公告)号：US20230309881A1

公开(公告)日：2023-10-05

申请号：US18180809

申请日：2023-03-08

Applicant: Dexcom, Inc.

Inventor： Peter C. Simpson ,  Ying Li ,  Apurv U. Kamath ,  Richard Yang

IPC: A61B5/157 ,  A61B5/00 ,  A61B5/145 ,  A61B5/1473 ,  A61B5/1486 ,  A61B5/1495 ,  A61B5/15 ,  A61B5/155 ,  C12Q1/00

CPC classification number: A61B5/157 ,  A61B5/0031 ,  A61B5/14532 ,  A61B5/14539 ,  A61B5/14542 ,  A61B5/14546 ,  A61B5/14735 ,  A61B5/1486 ,  A61B5/14865 ,  A61B5/1495 ,  A61B5/15003 ,  A61B5/150992 ,  A61B5/155 ,  A61B5/412 ,  A61B5/4839 ,  A61B5/6848 ,  A61B5/6849 ,  C12Q1/001 ,  C12Q1/006 ,  A61B5/14503 ,  A61B5/6866 ,  G16H20/17

Abstract: Systems and methods of use for continuous analyte measurement of a host's vascular system are provided. In some embodiments, a continuous glucose measurement system includes a vascular access device, a sensor and sensor electronics, the system being configured for insertion into communication with a host's circulatory system.

公开(公告)号：US20230293009A1

公开(公告)日：2023-09-21

申请号：US18184644

申请日：2023-03-15

Applicant: Dexcom, Inc.

Inventor： Jorge R. BARRERAS ,  Reinier SANCHEZ BAO

IPC: A61B5/00 ,  A61B5/145 ,  H04W48/10 ,  H04W76/10

CPC classification number: A61B5/0004 ,  A61B5/002 ,  A61B5/14532 ,  H04W48/10 ,  H04W76/10 ,  A61B2562/08

Abstract: Techniques and protocols for facilitating wireless secure communications between a sensor system and one or more other devices are disclosed. In certain embodiments, the techniques and protocols include secure proximity pairing techniques with reduced power. A method for pairing an analyte sensor system and one or more display devices includes broadcasting, from the analyte sensor system, for an initial connection, a low power general advertisement including an indication indicating the low power general advertisement is for proximity pairing. The method includes receiving, from a first display device, a connection request message in response to the low power general advertisement; performing an authentication procedure with the first display device; and pairing and bonding with the first display device based on successful authentication with the first display device.

公开(公告)号：US20230263479A1

公开(公告)日：2023-08-24

申请号：US18052194

申请日：2022-11-02

Applicant: Dexcom, Inc.

Inventor： Matthew Lawrence JOHNSON ,  Samuel Isaac EPSTEIN ,  Sarah Kate PICKUS ,  Lauren Hruby JEPSON ,  Kevin CHENG ,  Spencer Troy FRANK ,  Qi AN ,  Devon M. HEADEN ,  Abdulrahman JBAILY

IPC: A61B5/00 ,  A61B5/11 ,  G16H20/00 ,  A61B5/155 ,  A61B5/145

CPC classification number: A61B5/7275 ,  A61B5/1118 ,  G16H20/00 ,  A61B5/7203 ,  A61B5/155 ,  A61B5/14532

Abstract: Certain aspects of the present disclosure relate to methods and systems for predicting glycemic events in a patient induced as a result of physical activity. In certain aspects, a method includes monitoring a plurality of analytes of the patient continuously during a time period to obtain analyte data, the plurality of analytes including at least glucose and lactate. The method further includes processing the analyte data from the time period to determine an intensity level of physical activity engaged by the patient during the time period. The method further includes generating a glycemic event prediction using at least the analyte data for the plurality of analytes and the determination of physical activity intensity. The method further includes generating one or more recommendations for treatment for the patient based, at least in part, on the glycemic event prediction.

公开(公告)号：US20230263434A1

公开(公告)日：2023-08-24

申请号：US18173753

申请日：2023-02-23

Applicant: Dexcom, Inc.

Inventor： Matthew L. JOHNSON ,  Partha Pratim RAY ,  Qi AN ,  Rush BARTLETT ,  John PADERI

IPC: A61B5/145 ,  A61B5/1486 ,  A61B5/00 ,  A61B5/0205

CPC classification number: A61B5/14546 ,  A61B5/14865 ,  A61B5/7275 ,  A61B5/0205 ,  A61B5/7267 ,  A61B5/0004

Abstract: Certain aspects of the present disclosure relate to methods and systems for providing decision support around kidney disease. In certain aspects, a method includes monitoring one or more analytes of the patient during a plurality of time periods to obtain analyte data, the one or more analytes including at least potassium and the analyte data containing potassium data, processing the analyte data from the plurality of time periods to determine at least one rate of change of potassium for the patient based on the potassium data, and generating a disease prediction using the analyte data for the one or more analytes, including the potassium data and the at least one rate of change of potassium for the patient.

公开(公告)号：US11730402B2

公开(公告)日：2023-08-22

申请号：US17806933

申请日：2022-06-14

Applicant: Dexcom, Inc.

Inventor： Jose Hector Hernandez-Rosas ,  Shawn Larvenz ,  Mark Dervaes ,  Indrawati Gauba ,  Michael Robert Mensinger ,  Eric Cohen ,  Brian Christopher Smith ,  Jorge Valdes ,  Jacob S. Leach

IPC: A61B5/145 ,  H04Q9/14 ,  A61B5/00 ,  H04B7/26 ,  H04L67/12 ,  H04Q9/00 ,  A61B5/07 ,  H04W76/14 ,  H04W4/70 ,  H04W76/10 ,  H04W76/30 ,  H04W76/34

CPC classification number: A61B5/14503 ,  A61B5/0004 ,  A61B5/076 ,  A61B5/14532 ,  A61B5/742 ,  H04B7/26 ,  H04L67/12 ,  H04Q9/00 ,  H04Q9/14 ,  H04W4/70 ,  H04W76/10 ,  H04W76/14 ,  H04W76/30 ,  H04W76/34 ,  H04Q2209/40 ,  H04Q2209/50

Abstract: Systems and methods for a continuous monitoring of analyte values received from an analyte sensor system are provided. One method for a wireless data communication between an analyte sensor system and a mobile device involves storing identification information associated with a transceiver of the analyte sensor system, the identification information entered by a user of the mobile device via a custom application running on the mobile device; causing the custom application to enter a background mode; searching for advertisement signals; receiving an advertisement signal from the transceiver; authenticating the transceiver based on the identification information; prompting the user to bring the custom application to a foreground mode; causing the custom application to request a confirmation from the user that a data connection with the transceiver is desired; receiving the confirmation from the user; and completing the data connection with the transceiver.